| P50 | author | Thomas Kieber-Emmons | Q104746187 |
| P2093 | author name string | Behjatolah Monzavi-Karbassi | |
| | Ping Luo | |
| | Gina Cunto-Amesty | |
| | Fariba Jousheghany | |
| P2860 | cites work | Crystal structure of an MHC class I presented glycopeptide that generates carbohydrate-specific CTL | Q27639768 |
| | Crystal structures of two H-2Db/glycopeptide complexes suggest a molecular basis for CTL cross-reactivity | Q27639770 |
| | Structural evidence of T cell xeno-reactivity in the absence of molecular mimicry | Q27766708 |
| | Heparin inhibition of selectin-mediated interactions during the hematogenous phase of carcinoma metastasis: rationale for clinical studies in humans | Q28205943 |
| | Antigens derived from melanocyte differentiation proteins: self-tolerance, autoimmunity, and use for cancer immunotherapy | Q30310231 |
| | Antigenic and immunogenic phage displayed mimotopes as substitute antigens: applications and limitations | Q30662110 |
| | Towards the development of peptide mimotopes of carbohydrate antigens as cancer vaccines | Q30672273 |
| | Mimotopes of cytolytic T lymphocytes in cancer immunotherapy | Q30697868 |
| | Peptide mimotopes as surrogate antigens of carbohydrates in vaccine discovery | Q30729198 |
| | Mimics and cross reactions of relevance to tumour immunotherapy. | Q30783122 |
| | Selection of an immunogenic peptide mimic of the capsular polysaccharide of Neisseria meningitidis serogroup A using a peptide display library | Q30834954 |
| | Nucleic acid aptamers in cancer medicine | Q30854890 |
| | Mimotopes: realization of an unlikely concept | Q30976506 |
| | A family of concanavalin A-binding peptides from a hexapeptide epitope library | Q30989706 |
| | Recombinant MUC1 probe authentically reflects cell-specific O-glycosylation profiles of endogenous breast cancer mucin. High density and prevalent core 2-based glycosylation | Q31051680 |
| | Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry | Q31121392 |
| | Helix pomatia agglutinin lectin-binding oligosaccharides of aggressive breast cancer | Q32160147 |
| | Molecular characterization of a monoclonal antibody produced in response to a group C meningococcal polysaccharide peptide mimic | Q48065259 |
| | T cell recognition of Tn-glycosylated peptide antigens. | Q52047975 |
| | Carbohydrate expression profile of colorectal cancer cells is relevant to metastatic pattern and prognosis. | Q52842975 |
| | Mature dendritic cells induce T-helper type-1-dominant immune responses in patients with metastatic renal cell carcinoma. | Q52920409 |
| | Vaccination with carbohydrate peptide mimotopes promotes anti-tumor responses. | Q53892129 |
| | Synthetic carbohydrate vaccines: synthesis and immunogenicity of Tn antigen conjugates. | Q54625184 |
| | Conjugate vaccines. | Q55033615 |
| | Immunohistochemical expression of blood group substances and related carbohydrate antigens in breast carcinoma. | Q55398199 |
| | Vaccination of Metastatic Melanoma Patients With Autologous Tumor-Derived Heat Shock Protein gp96-Peptide Complexes: Clinical and Immunologic Findings | Q57570391 |
| | MUC1 cross-reactive Galα(l,3)Gal antibodies in humans switch immune responses from cellular to humoral | Q57594342 |
| | Peptide mimics of a tumor antigen induce functional cytotoxic T cells | Q57594346 |
| | Quantitative determination of TCR cross-reactivity using peptide libraries and protein databases | Q64166669 |
| | Immunization of breast cancer patients using a synthetic sialyl-Tn glycoconjugate plus Detox adjuvant | Q70577158 |
| | Immunization with glycosylated Kb-binding peptides generates carbohydrate-specific, unrestricted cytotoxic T cells | Q71011944 |
| | Enhancing the effect of THERATOPE STn-KLH cancer vaccine in patients with metastatic breast cancer by pretreatment with low-dose intravenous cyclophosphamide | Q71699068 |
| | Lectin purified human class I MHC-derived peptides: evidence for presentation of glycopeptides in vivo | Q73043780 |
| | Use of the anti-idiotype antibody vaccine TriAb after autologous stem cell transplantation in patients with metastatic breast cancer | Q73104285 |
| | Peptide mimicry of adenocarcinoma-associated carbohydrate antigens | Q73186780 |
| | On the immunogenic properties of retro-inverso peptides. Total retro-inversion of T-cell epitopes causes a loss of binding to MHC II molecules | Q73428233 |
| | T cells activated by zwitterionic molecules prevent abscesses induced by pathogenic bacteria | Q73509754 |
| | Exploiting molecular mimicry to broaden the immune response to carbohydrate antigens for vaccine development | Q73636617 |
| | Immunogenicity of recombinant GA733-2E antigen (CO17-1A, EGP, KS1-4, KSA, Ep-CAM) in gastro-intestinal carcinoma patients | Q73695514 |
| | Immunotherapy with vaccines combining MHC class II/CD80+ tumor cells with interleukin-12 reduces established metastatic disease and stimulates immune effectors and monokine induced by interferon gamma | Q73715471 |
| | Listeriolysin O-liposome-mediated cytosolic delivery of macromolecule antigen in vivo: enhancement of antigen-specific cytotoxic T lymphocyte frequency, activity, and tumor protection | Q74084363 |
| | Stuck in the MUC on the long and winding road | Q74310245 |
| | Generation of CTL recognizing an HLA-A*0201-restricted epitope shared by MAGE-A1, -A2, -A3, -A4, -A6, -A10, and -A12 tumor antigens: implication in a broad-spectrum tumor immunotherapy | Q74335031 |
| | Cancer immunotherapy: novel strategies and clinical experiences | Q74675064 |
| | Cytokine gene transfection for autologous and allogeneic melanoma vaccines | Q77442011 |
| | Antigenic and immunological mimicry of peptide mimotopes of Lewis carbohydrate antigens | Q77636169 |
| | DNA vaccines | Q77779217 |
| | Presentation of a major histocompatibility complex class 1-binding peptide by monocyte-derived dendritic cells incorporating hydrophobized polysaccharide-truncated HER2 protein complex: implications for a polyvalent immuno-cell therapy | Q78033398 |
| | Phase I study in cancer patients of a replication-defective avipox recombinant vaccine that expresses human carcinoembryonic antigen | Q78160862 |
| | Cross-presentation of HLA class I epitopes from exogenous NY-ESO-1 polypeptides by nonprofessional APCs | Q78826858 |
| | Identification of heat shock protein 90 and other proteins as tumour antigens by serological screening of an ovarian carcinoma expression library | Q33184085 |
| | Peptide ligands for a sugar-binding protein isolated from a random peptide library | Q33221384 |
| | Carbohydrate/peptide mimics: effect on MUC1 cancer immunotherapy | Q33699292 |
| | O-glycosylation of the mucin type | Q33942868 |
| | Helminth C-type lectins and host-parasite interactions | Q33971971 |
| | Antigen-processing machinery breakdown and tumor growth | Q34011098 |
| | Current concepts in cancer vaccine strategies | Q34150312 |
| | Identification of a human telomerase reverse transcriptase peptide of low affinity for HLA A2.1 that induces cytotoxic T lymphocytes and mediates lysis of tumor cells. | Q34155839 |
| | On the power of chemical synthesis: immunological evaluation of models for multiantigenic carbohydrate-based cancer vaccines. | Q34160588 |
| | A push-pull approach to maximize vaccine efficacy: abrogating suppression with an IL-13 inhibitor while augmenting help with granulocyte/macrophage colony-stimulating factor and CD40L | Q34191248 |
| | T cell-independent antigens type 2. | Q34300069 |
| | From cancer genomics to cancer immunotherapy: toward second-generation tumor antigens | Q34348874 |
| | Immune responses to tumour antigens: implications for antigen specific immunotherapy of cancer | Q34353878 |
| | O-linked glycosylation in the mammary gland: changes that occur during malignancy. | Q34362815 |
| | Peptide mimicry of the meningococcal group C capsular polysaccharide | Q34404304 |
| | Telomerase as a universal tumor-associated antigen for cancer immunotherapy | Q34535727 |
| | NKT cells - conductors of tumor immunity? | Q34547180 |
| | Clinical cancer vaccine trials | Q34547192 |
| | Natural killer T (NKT) cells and their role in antitumor immunity. | Q34552898 |
| | The potential of DNA vaccination against tumor-associated antigens for antitumor therapy | Q34574683 |
| | Human papillomavirus antigens and T-cell recognition | Q34616511 |
| | Spinning molecular immunology into successful immunotherapy | Q34632056 |
| | Cancer immunotherapy with peptide-based vaccines: what have we achieved? Where are we going? | Q34669820 |
| | Early detection of pancreatic carcinoma | Q34684186 |
| | Exploiting dendritic cells to improve vaccine efficacy | Q34691785 |
| | Generation of dendritic cell-based vaccines for cancer therapy | Q34708252 |
| | On the role of cell surface carbohydrates and their binding proteins (lectins) in tumor metastasis | Q34708719 |
| | Delivery technologies for human vaccines | Q34784860 |
| | Alphavirus vectors and vaccination | Q34812016 |
| | Adjuvants and the promotion of Th1-type cytokines in tumour immunotherapy | Q34971986 |
| | Universal tumor antigens as targets for immunotherapy | Q34979038 |
| | Peptide-based cancer vaccines | Q34983941 |
| | New aspects of natural-killer-cell surveillance and therapy of cancer | Q34988265 |
| | Adjuvant immunotherapy for solid tumors: from promise to clinical application | Q35002478 |
| | HPV protein/peptide vaccines: from animal models to clinical trials | Q35011108 |
| | CD8+ T cell tolerance and cancer immunotherapy | Q35039427 |
| | Anti-idiotype antibody vaccine therapy for cancer | Q35040841 |
| | Dendritic cell-based vaccines and therapies for cancer | Q35040857 |
| | Monoclonal antibody therapy for cancer | Q35044199 |
| | Priming characteristics of peptide mimotopes of carbohydrate antigens | Q35046997 |
| | Aspects of cancer immunotherapy | Q35048340 |
| | GD2 oligosaccharide: target for cytotoxic T lymphocytes | Q36365113 |
| | A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas | Q36371124 |
| | Induction of an antigen-specific, CD1-restricted cytotoxic T lymphocyte response In vivo | Q36400245 |
| | Peptide binding and presentation by mouse CD1. | Q36679018 |
| | Identification of a peptide which binds to the carbohydrate-specific monoclonal antibody B3 | Q36696075 |
| | Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy | Q37116373 |
| | Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein | Q37375709 |
| | A cryptococcal capsular polysaccharide mimotope prolongs the survival of mice with Cryptococcus neoformans infection | Q38305187 |
| | Altered saccharide sequences in two groups of patients with metastatic prostatic carcinoma | Q38306527 |
| | A molecular basis for functional peptide mimicry of a carbohydrate antigen | Q38313601 |
| | Altered glycosylation of membrane glycoproteins associated with human mammary carcinoma | Q38325472 |
| | Partial purification of tumour-specific transplantation antigens from methylcholanthrene-induced murine sarcomas by immobilized lectins | Q39584310 |
| | Activation of T cells via tumor antigen specific chimeric receptors: the role of the intracellular signaling domain | Q40684707 |
| | Autologous and MHC class I-negative allogeneic tumor cells secreting IL-12 together cure disseminated A20 lymphoma | Q40695034 |
| | Efficient priming of CD4+ and CD8+ T cells by DNA vaccination depends on appropriate targeting of sufficient levels of immunologically relevant antigen to appropriate processing pathways | Q40695595 |
| | A recombinant E. coli vaccine to promote MHC class I-dependent antigen presentation: application to cancer immunotherapy. | Q40697734 |
| | HER-2/neu and hTERT cryptic epitopes as novel targets for broad spectrum tumor immunotherapy | Q40730426 |
| | Fine specificity of TCR complementarity-determining region residues and lipid antigen hydrophilic moieties in the recognition of a CD1-lipid complex | Q40739748 |
| | Lipopeptide-based melanoma cancer vaccine induced a strong MART-27-35-cytotoxic T lymphocyte response in a preclinal study. | Q40749248 |
| | Lipo-oligosaccharides (LOS) of mucosal pathogens: molecular mimicry and host-modification of LOS. | Q40825138 |
| | Construction and characterization of DNA vaccines encoding the single-chain variable fragment of the anti-idiotype antibody 1A7 mimicking the tumor-associated antigen disialoganglioside GD2. | Q40835803 |
| | Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule | Q40840410 |
| | Cutting edge: DNA immunization with minigenes of carbohydrate mimotopes induce functional anti-carbohydrate antibody response | Q40870293 |
| | Peptide mimicry of carbohydrate epitopes on human immunodeficiency virus | Q41108126 |
| | Generation of Human Cytotoxic T Cells Specific for Human Carcinoembryonic Antigen Epitopes From Patients Immunized With Recombinant Vaccinia-CEA Vaccine | Q41327004 |
| | Molecular mimicry between Helicobacter pylori and the host | Q41435463 |
| | Recognition of carbohydrate by major histocompatibility complex class I-restricted, glycopeptide-specific cytotoxic T lymphocytes | Q41450537 |
| | Helix pomatia agglutinin binding in human tumour cell lines: correlation with pulmonary metastases in nude mice. | Q41462484 |
| | Glycosphingolipid antigens and cancer therapy | Q41504998 |
| | Metastatic potential of colon carcinoma. Expression of ABO/Lewis-related antigens | Q41745218 |
| | CD1--a new paradigm for antigen presentation and T cell activation | Q41759241 |
| | Immunization with a carbohydrate mimicking peptide augments tumor-specific cellular responses | Q43775914 |
| | An anti-idiotype vaccine elicits a specific response to N-glycolyl sialic acid residues of glycoconjugates in melanoma patients | Q43891725 |
| | T/Tn antigen vaccine is effective and safe in preventing recurrence of advanced human breast carcinoma | Q44553719 |
| | Amino acid sequence of protein alpha-amylase inhibitor from Streptomyces griseosporeus YM-25. | Q44862015 |
| | A retro-inverso peptide analogue of influenza virus hemagglutinin B-cell epitope 91-108 induces a strong mucosal and systemic immune response and confers protection in mice after intranasal immunization. | Q45731007 |
| | Anchoring cytokines to tumor cells for the preparation of anticancer vaccines without gene transfection in mice | Q45857555 |
| | Immune response to polyvalent melanoma cell vaccine in AJCC stage III melanoma: an immunologic survival model. | Q46022389 |
| | A novel cancer vaccine composed of human-recombinant epidermal growth factor linked to a carrier protein: report of a pilot clinical trial | Q47938719 |
| P433 | issue | 5-6 | |
| P304 | page(s) | 597-613 | |
| P577 | publication date | 2003-05-01 | |
| P1433 | published in | International Journal for Parasitology | Q6051284 |
| P1476 | title | Strategies in cancer vaccines development | |
| P478 | volume | 33 | |